Stéphanie Cabantous

Mr. Stéphanie Cabantous

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2005 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JPJean-Denis Pédelacq
Jean-Denis Pédelacq
SCStéphanie Cabantous
Stéphanie Cabantous
TTTimothy Tran
Timothy Tran
TTThomas C Terwilliger
Thomas C Terwilliger
GWGeoffrey S Waldo
Geoffrey S Waldo

1 January 2005 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
SCStéphanie Cabantous
Stéphanie Cabantous
TTThomas C Terwilliger
Thomas C Terwilliger
GWGeoffrey S Waldo
Geoffrey S Waldo

21 September 2006 in Nature Methods
Verified
Journal Article
Closed access
SCStéphanie Cabantous
Stéphanie Cabantous
GWGeoffrey S Waldo
Geoffrey S Waldo

4 October 2013 in Scientific Reports
Verified
Journal Article
Open access
SCStéphanie Cabantous
Stéphanie Cabantous
HNHau B. Nguyen
Hau B. Nguyen
JPJean-Denis Pedelacq
Jean-Denis Pedelacq
FKFaten Koraïchi
Faten Koraïchi
ACAnu Chaudhary
Anu Chaudhary
GWGeoffrey S. Waldo
Geoffrey S. Waldo
Monitoring protein-protein interactions in living cells is key to unraveling their roles in numerous cellular processes and various diseases. Previously described split-GFP based sensors suffer from poor folding and/or self-assembly background fluorescence. Here, we have engineered a micro-tagging system to monitor protein-protein interactions in vivo and in vitro. The assay is based on tripartite association between two twenty amino-acids long GFP tags, GFP10 and GFP11, fused to interacting protein partners, and the complementary GFP1-9 detector. When proteins interact, GFP10 and GFP11 self-associate with GFP1-9 to reconstitute a functional GFP. Using coiled-coils and FRB/FKBP12 model systems we characterize the sensor in vitro and in Escherichia coli. We extend the studies to mammalian cells and examine the FK-506 inhibition of the rapamycin-induced association of FRB/FKBP12. The small size of these tags and their minimal effect on fusion protein behavior and solubility should enable new experiments for monitoring protein-protein association by fluorescence.

Verified
Journal Article
Open access
PDF file
JPJean-Denis Pedelacq
Jean-Denis Pedelacq
SCStéphanie Cabantous
Stéphanie Cabantous
Molecular engineering of the green fluorescent protein (GFP) into a robust and stable variant named Superfolder GFP (sfGFP) has revolutionized the field of biosensor development and the use of fluorescent markers in diverse area of biology. sfGFP-based self-associating bipartite split-FP systems have been widely exploited to monitor soluble expression in vitro, localization, and trafficking of proteins in cellulo. A more recent class of split-FP variants, named « tripartite » split-FP, that rely on the self-assembly of three GFP fragments, is particularly well suited for the detection of protein–protein interactions. In this review, we describe the different steps and evolutions that have led to the diversification of superfolder and split-FP reporter systems, and we report an update of their applications in various areas of biology, from structural biology to cell biology.

20 December 2012 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CLCécile Leblanc
Cécile Leblanc
TPThomas Prudhomme
Thomas Prudhomme
GTGuillaume Tabouret
Guillaume Tabouret
ARAurélie Ray
Aurélie Ray
SBSophie Burbaud
Sophie Burbaud
CCChristian Chalut
Christian Chalut
The cell envelope of Mycobacterium tuberculosis, the causative agent of tuberculosis in humans, contains lipids with unusual structures. These lipids play a key role in both virulence and resistance to the various hostile environments encountered by the bacteria during infection. They are synthesized by complex enzymatic systems, including type-I polyketide synthases and type-I and -II fatty acid synthases, which require a post-translational modification to become active. This modification consists of the covalent attachment of the 4′-phosphopantetheine moiety of Coenzyme A catalyzed by phosphopantetheinyl transferases (PPTases). PptT, one of the two PPTases produced by mycobacteria, is involved in post-translational modification of various type-I polyketide synthases required for the formation of both mycolic acids and lipid virulence factors in mycobacteria. Here we identify PptT as a new target for anti-tuberculosis drugs; we address all the critical issues of target validation to demonstrate that PptT can be used to search for new drugs. We confirm that PptT is essential for the growth of M. bovis BCG in vitro and show that it is required for persistence of M. bovis BCG in both infected macrophages and immunodeficient mice. We generated a conditional expression mutant of M. tuberculosis, in which the expression of the pptT gene is tightly regulated by tetracycline derivatives. We used this construct to demonstrate that PptT is required for the replication and survival of the tubercle bacillus during the acute and chronic phases of infection in mice. Finally, we developed a robust and miniaturized assay based on scintillation proximity assay technology to search for inhibitors of PPTases, and especially of PptT, by high-throughput screening. Our various findings indicate that PptT meets the key criteria for being a therapeutic target for the treatment of mycobacterial infections. Mycobacterium tuberculosis, the causative agent of human tuberculosis, is responsible for more than 8 million new cases and 1.5 million deaths every year. Despite the existence of effective treatments, the emergence of resistance makes the need for new anti-tuberculosis drugs urgent. The cell envelope of the tubercle bacillus undoubtedly plays a key role in pathogenicity. The envelope has very high lipid content and contains lipids with unusual structures. Some of these lipids are synthesized by complex enzymatic systems that can only become functional after post-translational modification by a 4′-phosphopantetheinyl transferase named PptT. We report that PptT is essential for the viability of M. tuberculosis in vitro and of M. tuberculosis and its close relative M. bovis BCG in both macrophages and the mouse model. Our findings demonstrate that PptT plays a key role in multiplication and persistence of the tubercle bacillus and is therefore an attractive target for drug discovery. We also developed an in vitro assay that promises to be a powerful tool for high-throughput screening of PptT inhibitors.